Cardurion Pharmaceuticals

64 Sydney Street
Cambridge
Massachusetts
02139
United States

Email: info@cardurion.com

Show jobs for this employer

About Cardurion Pharmaceuticals

Cardurion is a recently launched, Boston-based cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. In July, 2017, Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new preclinical partnership to develop novel, next-generation therapeutics for the treatment of heart failure and cardiovascular diseases. The partnership with Cardurion follows Takeda’s strategy to leverage external innovation by placing selected assets and outstanding scientists in an entrepreneurial setting and enables the Discovery programs of Cardurion.
Cardurion is led by two distinguished physician-scientists with extensive experience in cardiovascular science, medicine and drug development: Daniel Bloomfield, M.D. chief executive officer and Michael Mendelsohn, M.D. founder and executive board chairman.
YEAR FOUNDED:
July 2017
LEADERSHIP:
Founder & Chairman: Michael E. Mendelsohn, M.D.
CEO: Daniel M. Bloomfield, M.D.

5 articles with Cardurion Pharmaceuticals